Literature DB >> 30561750

Slow-wave activity surrounding stage N2 K-complexes and daytime function measured by psychomotor vigilance test in obstructive sleep apnea.

Ankit Parekh, Anna E Mullins1, Korey Kam1, Andrew W Varga1, David M Rapoport1, Indu Ayappa1.   

Abstract

STUDY
OBJECTIVE: To better understand the inter-individual differences in neurobehavioral impairment in obstructive sleep apnea (OSA) and its treatment with continuous positive airway pressure (CPAP), we examined how changes in sleep electroencephalography (EEG) slow waves were associated with next-day psychomotor vigilance test (PVT) performance.
METHODS: Data from 28 OSA subjects (Apnea-Hypopnea Index with 3% desaturation and/or with an associated arousal [AHI3A] > 15/hour; AHI3A = sum of all apneas and hypopneas with 3% O2 desaturation and/or an EEG arousal, divided by total sleep time [TST]), who underwent three full in-lab nocturnal polysomnographies (NPSGs: chronic OSA, CPAP-treated OSA, and acute OSA), and 19 healthy sleepers were assessed. Four 20-minute PVTs were performed after each NPSG along with subjective and objective assessment of sleepiness. Three EEG metrics were calculated: K-complex (KC) Density (#/minute of N2 sleep), change in slow-wave activity in 1-second envelopes surrounding KCs (ΔSWAK), and relative frontal slow-wave activity during non-rapid eye movement (NREM) (%SWA).
RESULTS: CPAP treatment of OSA resulted in a decrease in KC Density (chronic: 3.9 ± 2.2 vs. treated: 2.7 ± 1.1; p < 0.01; mean ± SD) and an increase in ΔSWAK (chronic: 2.6 ± 2.3 vs. treated: 4.1 ± 2.4; p < 0.01) and %SWA (chronic: 20.9 ± 8.8 vs. treated: 26.6 ± 8.6; p < 0.001). Cross-sectionally, lower ΔSWAK values were associated with higher PVT Lapses (chronic: rho = -0.55, p < 0.01; acute: rho = -0.46, p = 0.03). Longitudinally, improvement in PVT Lapses with CPAP was associated with an increase in ΔSWAK (chronic to treated: rho = -0.48, p = 0.02; acute to treated: rho = -0.5, p = 0.03). In contrast, OSA severity or global sleep quality metrics such as arousal index, NREM, REM, or TST were inconsistently associated with PVT Lapses.
CONCLUSION: Changes in EEG slow waves, in particular ∆SWAK, explain inter-individual differences in PVT performance better than conventional NPSG metrics, suggesting that ΔSWAK is a night-time correlate of next-day vigilance in OSA. © Sleep Research Society 2018. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  EEG spectral analysis; K-complex; OSA; OSA–PAP therapy; excessive daytime sleepiness; psychomotor vigilance test; sleep-disordered breathing; slow-wave sleep

Mesh:

Year:  2019        PMID: 30561750      PMCID: PMC6424089          DOI: 10.1093/sleep/zsy256

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  69 in total

1.  Sleep architecture, slow wave activity and sleep spindles in mild sleep disordered breathing.

Authors:  B Ondze; F Espa; Y Dauvilliers; M Billiard; A Besset
Journal:  Clin Neurophysiol       Date:  2003-05       Impact factor: 3.708

Review 2.  Delta wave power: an independent sleep phenotype or epiphenomenon?

Authors:  Christopher J Davis; James M Clinton; Kathryn A Jewett; Mark R Zielinski; James M Krueger
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

3.  Power density in theta/alpha frequencies of the waking EEG progressively increases during sustained wakefulness.

Authors:  C Cajochen; D P Brunner; K Kräuchi; P Graw; A Wirz-Justice
Journal:  Sleep       Date:  1995-12       Impact factor: 5.849

4.  The slow (< 1 Hz) oscillation in reticular thalamic and thalamocortical neurons: scenario of sleep rhythm generation in interacting thalamic and neocortical networks.

Authors:  M Steriade; D Contreras; R Curró Dossi; A Nuñez
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

5.  Improvement of EEG slowing in OSAS after CPAP treatment.

Authors:  Sang Don Lee; Gawon Ju; Jeong-Whun Kim; In-Young Yoon
Journal:  J Psychosom Res       Date:  2012-05-07       Impact factor: 3.006

6.  One night's CPAP withdrawal in otherwise compliant OSA patients: marked driving impairment but good awareness of increased sleepiness.

Authors:  Ashleigh J Filtness; Louise A Reyner; James A Horne
Journal:  Sleep Breath       Date:  2011-09-06       Impact factor: 2.816

7.  Psychomotor Vigilance Test and Its Association With Daytime Sleepiness and Inflammation in Sleep Apnea: Clinical Implications.

Authors:  Yun Li; Alexandros Vgontzas; Ilia Kritikou; Julio Fernandez-Mendoza; Maria Basta; Slobodanka Pejovic; Jordan Gaines; Edward O Bixler
Journal:  J Clin Sleep Med       Date:  2017-09-15       Impact factor: 4.062

8.  Subjective sleepiness correlates negatively with global alpha (8-12 Hz) and positively with central frontal theta (4-8 Hz) frequencies in the human resting awake electroencephalogram.

Authors:  Arjen M Strijkstra; Domien G M Beersma; Berdine Drayer; Nynke Halbesma; Serge Daan
Journal:  Neurosci Lett       Date:  2003-04-03       Impact factor: 3.046

9.  Sleep loss impairs short and novel language tasks having a prefrontal focus.

Authors:  Y Harrison; J A Horne
Journal:  J Sleep Res       Date:  1998-06       Impact factor: 3.981

10.  [Obstructive sleep apnea: factors important for severe daytime sleepiness].

Authors:  Skaidrius Miliauskas; Raimundas Sakalauskas
Journal:  Medicina (Kaunas)       Date:  2003       Impact factor: 2.430

View more
  8 in total

Review 1.  Epidemiology, Physiology and Clinical Approach to Sleepiness at the Wheel in OSA Patients: A Narrative Review.

Authors:  Maria R Bonsignore; Carolina Lombardi; Simone Lombardo; Francesco Fanfulla
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

Review 2.  Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.

Authors:  Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga
Journal:  Neurobiol Dis       Date:  2020-08-27       Impact factor: 5.996

3.  Altered K-complex morphology during sustained inspiratory airflow limitation is associated with next-day lapses in vigilance in obstructive sleep apnea.

Authors:  Ankit Parekh; Korey Kam; Anna E Mullins; Bresne Castillo; Asem Berkalieva; Madhu Mazumdar; Andrew W Varga; Danny J Eckert; David M Rapoport; Indu Ayappa
Journal:  Sleep       Date:  2021-07-09       Impact factor: 5.849

4.  Severe desaturations increase psychomotor vigilance task-based median reaction time and number of lapses in obstructive sleep apnoea patients.

Authors:  Samu Kainulainen; Brett Duce; Henri Korkalainen; Arie Oksenberg; Akseli Leino; Erna S Arnardottir; Antti Kulkas; Sami Myllymaa; Juha Töyräs; Timo Leppänen
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

5.  Effects of Continuous Positive Airway Pressure on Sleep EEG Characteristics in Patients with Primary Central Sleep Apnea Syndrome.

Authors:  Cheng Zhang; Kun Chen; Guangfa Wang; Jue Zhang; Jing Ma
Journal:  Can Respir J       Date:  2021-04-22       Impact factor: 2.409

6.  Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.

Authors:  Thomas Roth; Yves Dauvilliers; Michael J Thorpy; Clete Kushida; Bruce C Corser; Richard Bogan; Russell Rosenberg; Jordan Dubow; David Seiden
Journal:  CNS Drugs       Date:  2022-04-05       Impact factor: 5.749

7.  Effects of continuous positive airway pressure treatment on sleep architecture in adults with obstructive sleep apnea and type 2 diabetes.

Authors:  Kristine A Wilckens; Bomin Jeon; Jonna L Morris; Daniel J Buysse; Eileen R Chasens
Journal:  Front Hum Neurosci       Date:  2022-09-08       Impact factor: 3.473

8.  Effects of obstructive sleep apnea on human spatial navigational memory processing in cognitively normal older individuals.

Authors:  Anna E Mullins; Masrai K Williams; Korey Kam; Ankit Parekh; Omonigho M Bubu; Bresne Castillo; Zachary J Roberts; David M Rapoport; Indu Ayappa; Ricardo S Osorio; Andrew W Varga
Journal:  J Clin Sleep Med       Date:  2021-05-01       Impact factor: 4.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.